Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

Revenue by Segment

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Pharmaceutical Business	8.78B	7.25B	8.33B
Pharmaceutical Business Growth	21.24%	-13.04%	-
Total	8.78B	7.25B	8.33B
Total Growth	21.24%	-13.04%	-

Revenue by Geography

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
India	7.15B	6.56B	7.07B
India Growth	8.98%	-7.16%	-
Outside India	1.64B	686.00M	1.27B
Outside India Growth	138.48%	-45.81%	-
Total	8.78B	7.25B	8.33B
Total Growth	21.24%	-13.04%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error